Glycoprotein 88 (GP-88) serum levels as a marker of response to therapy in patients with metastatic breast cancer

被引：0
|
作者：
Tkaczuk, Katherine H. R.
Rosenbatt, Paula
Sulkowski, Sarah
Tait, Nancy
Yue, Binbin
Serrero, Ginette
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
PROGRANULIN; SURVIVAL;
D O I：
10.1158/1538-7445.SABCS21-OT1-05-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-05-01
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A prospective study of glycoprotein 88 (GP-88) blood test in healthy women undergoing screening for breast cancer (BC) with mammography (MM)
    Tkaczuk, K. H. R.
    Campassi, C.
    Kesmodel, S.
    Bellavance, E.
    Rosenblatt, P.
    Nichols, E.
    Feigenberg, S. J.
    Coughlin, P.
    Drogula, C.
    Urban, B.
    Galandak, J.
    Dromi, S.
    Kuo, L.
    Yue, B.
    Hicks, D.
    Serrero, G.
    CANCER RESEARCH, 2016, 76
  • [2] Determination of serum progranulin (GP88) levels complements CA15-3 to monitor disease progression & response to therapy in metastatic breast cancer patients
    Serrero, Ginette
    Tkaczuk, Katherine R.
    Hawkins, Douglas
    Tait, Nancy
    Yue, Binbin
    CANCER RESEARCH, 2021, 81 (04)
  • [3] Increased levels of the circulating growth factor GP88 in the serum of breast cancer patients
    Serrero, G
    Tkaczuk, KH
    Golubeva, O
    Jones, L
    Tait, N
    Feldman, FS
    Dai, H
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S84 - S84
  • [4] A prospective study of glycoprotein 88 GP-88 blood test in healthy women with Gail model risk <=1.66 undergoing screening for breast cancer (BC) with mammography (MM)
    Tkaczuk, Katherine Hr
    Campassi, Cristina
    Kesmodel, Susan
    Bellavance, Emily
    Olson, John
    Nichols, Elizabeth
    Feigenberg, Steven J.
    Yue, Binbin
    Hicks, David
    Serrero, Ginette
    CANCER RESEARCH, 2015, 75
  • [5] On-going prospective study to measure serum progranulin/GP88 levels in metastatic breast cancer patients in association with disease status
    Serrero, Ginette
    Rosenblatt, Paula
    Tait, Nancy
    Rector, Barbara
    Latteri, Jennifer A.
    Yue, Binbin
    Tkaczuk, Katherine
    CANCER RESEARCH, 2023, 83 (05)
  • [6] GP88 Serum Level Is Increased in Breast Cancer Patients with Disease Progression
    Serrero, G.
    Tkaczuk, K.
    Yue, B.
    Kamimura, S.
    Tait, N.
    Zhan, M.
    Ecklund, D.
    CANCER RESEARCH, 2009, 69 (24) : 836S - 836S
  • [7] Determination of a serum progranulin (GP88/PGRN) level associated with overall survival in metastatic breast cancer patients
    Serrero, G.
    Hawkins, D. M.
    Yue, B.
    Hicks, D.
    Tait, N.
    Tkaczuk, K. R.
    CANCER RESEARCH, 2017, 77
  • [8] Serum progranulin (GP88) level correlates with change in RECIST and survival in metastatic breast cancer
    Serrero, Ginette
    Hicks, David
    Hawkins, Douglas
    Yue, Binbin
    Rosenblatt, Paula
    Tait, Nancy
    Tkaczuk, Katherine
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Circulating progranulin (GP88/PGRN) level correlates with survival in metastatic breast cancer patients
    Serrero, Ginette
    Hicks, David
    Yue, Binbin
    Hawkins, Douglas M.
    Tait, Nancy
    Tkaczuk, Katherine H.
    CANCER RESEARCH, 2016, 76
  • [10] Elevated serum levels of the growth factor GP88 are found in breast cancer patients when compared to healthy individuals.
    Serrero, G.
    Tkaczuk, K.
    Zhan, M.
    Tait, N.
    Ilan, C.
    Yue, B.
    CANCER RESEARCH, 2009, 69 (02) : 158S - 158S
12345